|
VPS28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.648200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.859900E-02 |
| Normal-vs-Stage2 |
4.185000E-01 |
| Normal-vs-Stage3 |
4.702100E-02 |
| Normal-vs-Stage4 |
8.461700E-03 |
| Stage1-vs-Stage2 |
7.782400E-01 |
| Stage1-vs-Stage3 |
5.665600E-01 |
| Stage1-vs-Stage4 |
2.155800E-01 |
| Stage2-vs-Stage3 |
5.424200E-01 |
| Stage2-vs-Stage4 |
2.831800E-01 |
| Stage3-vs-Stage4 |
4.626800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.480100E-02 |
| Normal-vs-AfricanAmerican |
1.584370E-01 |
| Normal-vs-Asian |
1.243850E-01 |
| Caucasian-vs-AfricanAmerican |
7.590600E-01 |
| Caucasian-vs-Asian |
8.599600E-01 |
| AfricanAmerican-vs-Asian |
8.673600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.355040E-01 |
| Normal-vs-Female |
2.363800E-02 |
| Male-vs-Female |
6.198800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.132820E-01 |
| Normal-vs-Age(41-60Yrs) |
7.964000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.044300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.422370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.113200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.065800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.979200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.191000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.989200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.969400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.895700E-02 |
| Classical-VS-Follicular |
1.956550E-01 |
| Classical-VS-Other |
9.272400E-01 |
| Classical-VS-Normal |
1.514170E-02 |
| Tall-VS-Follicular |
1.455690E-02 |
| Tall-VS-Other |
3.021600E-01 |
| Tall-VS-Normal |
1.141970E-03 |
| Follicular-VS-Other |
7.345800E-01 |
| Follicular-VS-Normal |
5.049800E-01 |
| Other-VS-Normal |
3.679200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.522000E-01 |
| Normal-vs-N1 |
5.385800E-02 |
| N0-vs-N1 |
1.190960E-01 |
|
|
